GB9316895D0
(en)
*
|
1993-08-13 |
1993-09-29 |
Guy S And St Thomas Hospitals |
Hepatoselective insulin analogues
|
US6342225B1
(en)
|
1993-08-13 |
2002-01-29 |
Deutshces Wollforschungsinstitut |
Pharmaceutical active conjugates
|
US6869930B1
(en)
*
|
1993-09-17 |
2005-03-22 |
Novo Nordisk A/S |
Acylated insulin
|
DE4437604A1
(de)
*
|
1994-10-21 |
1996-04-25 |
Basf Ag |
Konjugate aus einem Poly- oder Oligopeptid und einer niedermolekularen lipophilen Verbindung
|
US5646242A
(en)
*
|
1994-11-17 |
1997-07-08 |
Eli Lilly And Company |
Selective acylation of epsilon-amino groups
|
US5693609A
(en)
*
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
CZ289343B6
(cs)
*
|
1995-03-17 |
2002-01-16 |
Novo Nordisk A/S |
Inzulinový derivát a farmaceutický prostředek pro léčení diabetes
|
US6251856B1
(en)
|
1995-03-17 |
2001-06-26 |
Novo Nordisk A/S |
Insulin derivatives
|
US20010041786A1
(en)
*
|
1995-06-07 |
2001-11-15 |
Mark L. Brader |
Stabilized acylated insulin formulations
|
GB9513967D0
(en)
*
|
1995-07-08 |
1995-09-06 |
Univ Leicester |
Insulin
|
US6451970B1
(en)
|
1996-02-21 |
2002-09-17 |
Novo Nordisk A/S |
Peptide derivatives
|
AU720484B2
(en)
*
|
1996-06-20 |
2000-06-01 |
Novo Nordisk A/S |
Insulin preparations containing NaCl
|
US5905140A
(en)
*
|
1996-07-11 |
1999-05-18 |
Novo Nordisk A/S, Novo Alle |
Selective acylation method
|
EP0938502B1
(fr)
*
|
1996-07-11 |
2004-10-06 |
Novo Nordisk A/S |
Procede selectif d'alcylation
|
US20020025933A1
(en)
*
|
1996-08-30 |
2002-02-28 |
Knudsen Liselotte Bjerre |
GLP-2 derivatives
|
US6268343B1
(en)
|
1996-08-30 |
2001-07-31 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US7235627B2
(en)
|
1996-08-30 |
2007-06-26 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US6458924B2
(en)
|
1996-08-30 |
2002-10-01 |
Novo Nordisk A/S |
Derivatives of GLP-1 analogs
|
US5898067A
(en)
*
|
1997-02-07 |
1999-04-27 |
Novo Nordisk A/S |
Crystallization of proteins
|
US6310038B1
(en)
|
1997-03-20 |
2001-10-30 |
Novo Nordisk A/S |
Pulmonary insulin crystals
|
EP1627642A3
(fr)
*
|
1997-03-20 |
2006-04-19 |
Novo Nordisk A/S |
Cristaux d'insuline depourvus de zinc et utiles dans des compositions pour les voies respiratoires
|
US6043214A
(en)
*
|
1997-03-20 |
2000-03-28 |
Novo Nordisk A/S |
Method for producing powder formulation comprising an insulin
|
US6444641B1
(en)
|
1997-10-24 |
2002-09-03 |
Eli Lilly Company |
Fatty acid-acylated insulin analogs
|
ZA989644B
(en)
*
|
1997-10-24 |
2000-04-25 |
Lilly Co Eli |
Insoluble insulen compositions.
|
US6451762B1
(en)
|
1997-10-24 |
2002-09-17 |
Novo Nordisk A/S |
Aggregates of human insulin derivatives
|
PE123799A1
(es)
*
|
1997-10-24 |
1999-12-13 |
Lilly Co Eli |
Composiciones insolubles de insulina
|
ZA989744B
(en)
*
|
1997-10-31 |
2000-04-26 |
Lilly Co Eli |
Method for administering acylated insulin.
|
US6531448B1
(en)
*
|
1997-12-23 |
2003-03-11 |
Eli Lilly And Company |
Insoluble compositions for controlling blood glucose
|
EP1396272A1
(fr)
*
|
1997-12-23 |
2004-03-10 |
Eli Lilly & Company |
Compositions insolubles d'insuline pour le contrôle du glucose sanguin
|
JP2002500196A
(ja)
*
|
1998-01-09 |
2002-01-08 |
ノヴォ ノルディスク アクティーゼルスカブ |
安定化させたインスリン組成物
|
AU2712899A
(en)
*
|
1998-02-27 |
1999-09-15 |
Novo Nordisk A/S |
Glp-2 derivatives with helix-content exceeding 25 percent, forming partially structured micellar-like aggregates
|
DE19825447A1
(de)
*
|
1998-06-06 |
1999-12-09 |
Hoechst Marion Roussel De Gmbh |
Neue Insulinanaloga mit erhöhter Zinkbildung
|
JP2002518408A
(ja)
*
|
1998-06-12 |
2002-06-25 |
キングス・カレツジ・ロンドン |
インスリン類似体
|
US7169889B1
(en)
*
|
1999-06-19 |
2007-01-30 |
Biocon Limited |
Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
|
WO2001072323A2
(fr)
|
2000-03-24 |
2001-10-04 |
Genentech, Inc. |
Utilisation de l'insuline pour traiter des affections des cartilages
|
WO2001085256A2
(fr)
*
|
2000-05-05 |
2001-11-15 |
Novo Nordisk A/S |
Maladie neurophatique grave
|
US7316999B2
(en)
|
2000-06-02 |
2008-01-08 |
Novo Nordisk A/S |
Glucose dependent release of insulin from glucose sensing insulin derivatives
|
CA2415425A1
(fr)
*
|
2000-07-10 |
2002-01-17 |
Btg International Limited |
Derives d'insuline et synthese desdits derives
|
CN1406131A
(zh)
*
|
2000-12-25 |
2003-03-26 |
株式会社资生堂 |
活化交感神经的香料组合物
|
US6867183B2
(en)
*
|
2001-02-15 |
2005-03-15 |
Nobex Corporation |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7060675B2
(en)
*
|
2001-02-15 |
2006-06-13 |
Nobex Corporation |
Methods of treating diabetes mellitus
|
US6653492B2
(en)
|
2001-05-02 |
2003-11-25 |
Novo Nordick A/S |
Preparation of bile acids
|
EP1698636A1
(fr)
*
|
2001-05-02 |
2006-09-06 |
Novo Nordisk A/S |
Procédé de préparation de conjagates de peptides avec des acides biliaire
|
US6835802B2
(en)
*
|
2001-06-04 |
2004-12-28 |
Nobex Corporation |
Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
|
US7713932B2
(en)
*
|
2001-06-04 |
2010-05-11 |
Biocon Limited |
Calcitonin drug-oligomer conjugates, and uses thereof
|
US6828305B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6828297B2
(en)
*
|
2001-06-04 |
2004-12-07 |
Nobex Corporation |
Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6713452B2
(en)
*
|
2001-06-04 |
2004-03-30 |
Nobex Corporation |
Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US6858580B2
(en)
*
|
2001-06-04 |
2005-02-22 |
Nobex Corporation |
Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
|
US7595172B2
(en)
|
2001-07-24 |
2009-09-29 |
Novo Nordisk A/S |
Method for making acylated polypeptides
|
MXPA04001560A
(es)
|
2001-08-28 |
2004-05-17 |
Lilly Co Eli |
Premezclas de glp-1 e insulina basal.
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
US6913903B2
(en)
*
|
2001-09-07 |
2005-07-05 |
Nobex Corporation |
Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
ATE446971T1
(de)
|
2001-09-07 |
2009-11-15 |
Biocon Ltd |
Verfahren zur synthese von insulinpolypeptid- oligomer-konjugaten und proinsulinpolypeptid- oligomer-konjugaten und verfahren zu deren synthese
|
US7196059B2
(en)
*
|
2001-09-07 |
2007-03-27 |
Biocon Limited |
Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
|
US7166571B2
(en)
*
|
2001-09-07 |
2007-01-23 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
US7312192B2
(en)
*
|
2001-09-07 |
2007-12-25 |
Biocon Limited |
Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
|
WO2003031432A1
(fr)
|
2001-10-12 |
2003-04-17 |
Novo Nordisk A/S |
Nouvelles piperidines substituees
|
CA2463803A1
(fr)
|
2001-10-19 |
2003-05-01 |
Eli Lilly And Company |
Melanges biphasiques de glp-1 et d'insuline
|
BR0213583A
(pt)
|
2001-11-19 |
2004-08-24 |
Novo Nordisk As |
Processo para preparar um composto de insulina, e, composto de insulina
|
GB0206792D0
(en)
|
2002-03-22 |
2002-05-01 |
Leuven K U Res & Dev |
Normoglycemia
|
JP5599543B2
(ja)
*
|
2002-05-07 |
2014-10-01 |
ノヴォ ノルディスク アー/エス |
単量体インスリン及びアシル化インスリンを含む可溶性製剤
|
US20040038864A1
(en)
*
|
2002-06-27 |
2004-02-26 |
Per Balschmidt |
Use of dimethyl sulfone as isotonicity agent
|
KR101131783B1
(ko)
*
|
2002-09-25 |
2012-03-30 |
노보 노르디스크 에이/에스 |
아실화된 펩타이드의 제조방법
|
US7273921B2
(en)
|
2002-09-25 |
2007-09-25 |
Novo Nordisk A/S |
Method for producing acylated peptides
|
US7411039B2
(en)
|
2002-10-14 |
2008-08-12 |
Novo Nordisk A/S |
GLP-2 compounds, formulations, and uses thereof
|
US20040138099A1
(en)
*
|
2002-11-29 |
2004-07-15 |
Draeger Eberhard Kurt |
Insulin administration regimens for the treatment of subjects with diabetes
|
WO2004085472A1
(fr)
*
|
2003-03-27 |
2004-10-07 |
Novo Nordisk A/S |
Procede de fabrication de precurseurs de l'insuline humaine et insuline humaine
|
ATE482747T1
(de)
|
2003-04-11 |
2010-10-15 |
High Point Pharmaceuticals Llc |
Neue amide derivate und deren pharmazeutische verwendungen
|
WO2004096266A1
(fr)
*
|
2003-05-02 |
2004-11-11 |
Novo Nordisk A/S |
Stabilite physique amelioree de preparations d'insuline
|
PL1641616T3
(pl)
|
2003-06-27 |
2011-09-30 |
Novo Nordisk As |
Wysoce wilgocioszczelny pojemnik dla medycznych mieszanin ciekłych
|
ES2472421T3
(es)
|
2003-08-05 |
2014-07-01 |
Novo Nordisk A/S |
Nuevos derivados de insulina
|
EP2264065B1
(fr)
|
2003-08-05 |
2017-03-08 |
Novo Nordisk A/S |
Nouveaux derives de l'insuline
|
EP1687428A1
(fr)
|
2003-11-14 |
2006-08-09 |
Novo Nordisk A/S |
Procede de fabrication d'insuline acylee
|
CN102784386A
(zh)
|
2003-11-20 |
2012-11-21 |
诺沃挪第克公司 |
对于生产和用于注射装置中是最佳的含有丙二醇的肽制剂
|
ATE517119T1
(de)
|
2003-12-03 |
2011-08-15 |
Novo Nordisk As |
Einzelketteninsulin
|
CN1898087A
(zh)
|
2003-12-22 |
2007-01-17 |
诺沃挪第克公司 |
用于储存药物液体的透明、柔性、不可渗透的塑料容器
|
CA2552043A1
(fr)
|
2004-01-21 |
2005-08-04 |
Novo Nordisk A/S |
Conjugaison de peptides induite par la transglutaminase
|
AU2005222613B2
(en)
*
|
2004-03-12 |
2009-12-17 |
Biodel, Inc. |
Rapid acting drug delivery compositions
|
WO2006008238A1
(fr)
*
|
2004-07-16 |
2006-01-26 |
Novo Nordisk A/S |
Procede d'acylation selective
|
UA103758C2
(ru)
|
2004-07-19 |
2013-11-25 |
Биокон Лимитед |
Конъюгаты олигомеров инсулина, их композиции и применение
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
WO2006082205A1
(fr)
*
|
2005-02-02 |
2006-08-10 |
Novo Nordisk A/S |
Dérivés d'insuline
|
ES2438145T3
(es)
|
2005-02-02 |
2014-01-16 |
Novo Nordisk A/S |
Nuevos derivados de insulina
|
US20090060861A1
(en)
*
|
2005-05-25 |
2009-03-05 |
Novo Nordisk A/S |
Stabilized Polypeptide Formulations
|
CN101180081B
(zh)
|
2005-05-25 |
2015-08-26 |
诺沃-诺迪斯克有限公司 |
稳定的多肽制剂
|
EP1888104A2
(fr)
*
|
2005-05-26 |
2008-02-20 |
Novo Nordisk A/S |
Insuline acylee tres pure
|
MX2007015675A
(es)
|
2005-07-04 |
2008-02-20 |
Novo Nordisk As |
Antagonistas del receptor de histamina h3.
|
EP1910317B1
(fr)
|
2005-07-20 |
2013-07-03 |
Eli Lilly And Company |
Composés joints en position 1-amino
|
WO2007020256A1
(fr)
|
2005-08-16 |
2007-02-22 |
Novo Nordisk A/S |
Procede permettant de realiser des polypeptides d'insuline matures
|
US7741281B2
(en)
*
|
2005-11-03 |
2010-06-22 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
WO2007123581A1
(fr)
|
2005-11-17 |
2007-11-01 |
Eli Lilly And Company |
Antagonistes des récepteurs du glucagon, leur préparation et leurs utilisations thérapeutiques
|
PT1969004E
(pt)
|
2005-12-28 |
2011-11-25 |
Novo Nordisk As |
Composições que compreendem uma insulina acilada e zinco e método para criar tais composições
|
WO2007084460A2
(fr)
|
2006-01-18 |
2007-07-26 |
Qps, Llc |
Compositions pharmaceutiques a stabilite amelioree
|
ATE557037T1
(de)
|
2006-02-27 |
2012-05-15 |
Novo Nordisk As |
Insulin derivate
|
EP1996223A1
(fr)
*
|
2006-03-13 |
2008-12-03 |
Novo Nordisk A/S |
Insuline monocaténaire acylée
|
WO2007104786A1
(fr)
|
2006-03-15 |
2007-09-20 |
Novo Nordisk A/S |
Melanges d'amyline et d'insuline
|
NZ570524A
(en)
|
2006-03-28 |
2011-08-26 |
High Point Pharmaceuticals Llc |
Benzothiazoles having histamine H3 receptor activity
|
ES2378574T3
(es)
|
2006-04-24 |
2012-04-16 |
Eli Lilly & Company |
Pirrolidinonas ciclohexilo substituidas como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa 1
|
CN101437849B
(zh)
*
|
2006-05-09 |
2015-09-30 |
诺沃-诺迪斯克有限公司 |
胰岛素衍生物
|
ES2548393T3
(es)
|
2006-05-09 |
2015-10-16 |
Novo Nordisk A/S |
Derivado de insulina
|
ES2553154T3
(es)
|
2006-05-09 |
2015-12-04 |
Novo Nordisk A/S |
Derivado de la insulina
|
US7714025B2
(en)
*
|
2006-05-10 |
2010-05-11 |
Arizona Biomedical Research Commission |
Modified chalcone compounds as antimitotic agents
|
CN101460487A
(zh)
|
2006-05-29 |
2009-06-17 |
高点制药有限责任公司 |
3-(1,3-苯并间二氧杂环戊烯- 5-基)-6-(4-环丙基哌嗪-1-基)-哒嗪、其盐和溶剂合物及其作为组胺h3受体拮抗剂的用途
|
WO2008008363A1
(fr)
|
2006-07-11 |
2008-01-17 |
Qps, Llc |
Compositions pharmaceutiques pour délivrance à libération prolongée de peptides
|
JP5550338B2
(ja)
|
2006-07-31 |
2014-07-16 |
ノボ・ノルデイスク・エー/エス |
ペグ化持続型インスリン
|
CN101541830A
(zh)
|
2006-09-22 |
2009-09-23 |
诺沃-诺迪斯克有限公司 |
蛋白酶抗性的胰岛素类似物
|
WO2008037735A1
(fr)
|
2006-09-27 |
2008-04-03 |
Novo Nordisk A/S |
Procédé de fabrication de polypeptides d'insuline mature
|
WO2008049711A1
(fr)
*
|
2006-10-27 |
2008-05-02 |
Novo Nordisk A/S |
Insuline à peptide ajouté
|
ES2563038T3
(es)
|
2007-04-30 |
2016-03-10 |
Novo Nordisk A/S |
Método para secar una composición proteica, una composición proteica seca y una composición farmacéutica que comprende la proteína seca
|
JP2011504871A
(ja)
|
2007-06-01 |
2011-02-17 |
ノボ・ノルデイスク・エー/エス |
固体又は半固体担体中にペプチド薬剤を含む自然に分散可能なプレコンセントレイト
|
JP5675347B2
(ja)
|
2007-06-01 |
2015-02-25 |
ノボ・ノルデイスク・エー/エス |
安定した非水性薬学的組成物
|
ES2744384T3
(es)
|
2007-06-13 |
2020-02-24 |
Novo Nordisk As |
Formulación farmacéutica que comprende un derivado de insulina
|
EP2178909B1
(fr)
|
2007-08-13 |
2015-10-21 |
Novo Nordisk A/S |
Analogues de l'insuline à action rapide
|
BRPI0818004B8
(pt)
*
|
2007-10-16 |
2021-05-25 |
Biocon Ltd |
composição farmacêutica sólida administrável por via oral e o processo da mesma.
|
EP2058330A1
(fr)
*
|
2007-11-08 |
2009-05-13 |
Novo Nordisk A/S |
Dérivé d'insuline
|
ES2543393T3
(es)
|
2007-11-08 |
2015-08-18 |
Novo Nordisk A/S |
Derivado de insulina
|
PL2209800T3
(pl)
|
2007-11-16 |
2013-12-31 |
Novo Nordisk As |
Stabilne kompozycje farmaceutyczne zawierające liraglutyd i degludec
|
AU2009204309B2
(en)
*
|
2008-01-04 |
2012-11-22 |
Biodel, Inc. |
Insulin formulations for insulin release as a function of tissue glucose levels
|
ES2618073T3
(es)
|
2008-03-14 |
2017-06-20 |
Novo Nordisk A/S |
Análogos de insulina estabilizados frente a proteasas
|
EP2910571B1
(fr)
|
2008-03-18 |
2016-10-05 |
Novo Nordisk A/S |
Analogues de l'insuline acylés, stabilisés à la protéase
|
TWI451876B
(zh)
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
BRPI0823004B8
(pt)
|
2008-08-07 |
2021-05-25 |
Biocon Ltd |
processo para preparação de compostos de insulina
|
US9603904B2
(en)
|
2008-10-30 |
2017-03-28 |
Novo Nordisk A/S |
Treating diabetes melitus using insulin injections with less than daily injection frequency
|
CN102223797A
(zh)
|
2008-11-21 |
2011-10-19 |
高点制药有限责任公司 |
金刚烷基苯甲酰胺化合物
|
WO2010088286A1
(fr)
|
2009-01-28 |
2010-08-05 |
Smartcells, Inc. |
Conjugués synthétiques et leurs utilisations
|
MA33064B1
(fr)
*
|
2009-01-28 |
2012-02-01 |
Smartcells Inc |
Systemes à base de conjugués pour administration contrôlée de médicaments
|
US9060927B2
(en)
*
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
WO2010107519A1
(fr)
|
2009-03-20 |
2010-09-23 |
Smartcells, Inc. |
Conjugués fonctionnalisés aux extrémités et leurs utilisations
|
EP2437786B1
(fr)
|
2009-06-01 |
2016-05-18 |
Yeda Research and Development Co. Ltd. |
Promédicaments contenant une sonde se liant à l'albumine
|
WO2011064316A2
(fr)
|
2009-11-25 |
2011-06-03 |
Paolo Botti |
Administration de peptides par voie muqueuse
|
EP2359843A1
(fr)
|
2010-01-21 |
2011-08-24 |
Sanofi |
Composition pharmaceutique pour le traitement d'un syndrome métabolique
|
US9981017B2
(en)
|
2010-04-02 |
2018-05-29 |
Hanmi Science Co., Ltd. |
Insulin conjugate using an immunoglobulin fragment
|
AR081066A1
(es)
|
2010-04-02 |
2012-06-06 |
Hanmi Holdings Co Ltd |
Conjugado de insulina donde se usa un fragmento de inmunoglobulina
|
TW201141513A
(en)
|
2010-04-14 |
2011-12-01 |
Sanofi Aventis |
Insulin-siRNA conjugates
|
AU2011252127B2
(en)
*
|
2010-05-10 |
2014-02-20 |
Novo Nordisk A/S |
Process for the preparation of insulin-zinc complexes
|
EP2627670A2
(fr)
*
|
2010-10-15 |
2013-08-21 |
Novo Nordisk A/S |
Nouveaux dérivés d'insuline à extrémité n modifiée
|
BR112013010345A2
(pt)
|
2010-10-27 |
2017-07-25 |
Novo Nordisk As |
tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção
|
KR102025442B1
(ko)
|
2010-12-22 |
2019-09-25 |
박스알타 인코퍼레이티드 |
단백질에 수용성 지방산 유도체를 접합하기 위한 물질 및 방법
|
AU2012208349A1
(en)
|
2011-01-20 |
2013-07-18 |
Zealand Pharma A/S |
Combination of acylated glucagon analogues with insulin analogues
|
US10130684B2
(en)
|
2011-02-03 |
2018-11-20 |
Pharmedica Ltd. |
Oral dissolving films for insulin administration, for treating diabetes
|
US9480751B2
(en)
|
2011-04-11 |
2016-11-01 |
Yeda Research And Development Co. Ltd. |
Albumin binding probes and drug conjugates thereof
|
EP2548570A1
(fr)
|
2011-07-19 |
2013-01-23 |
Sanofi |
Composition pharmaceutique pour le traitement d'un syndrome métabolique
|
CN102504022A
(zh)
*
|
2011-11-30 |
2012-06-20 |
苏州元基生物技术有限公司 |
含有保护赖氨酸的胰岛素原及使用其制备胰岛素的方法
|
WO2013086927A1
(fr)
*
|
2011-12-15 |
2013-06-20 |
上海恒瑞医药有限公司 |
Analogue d'insuline humaine et son dérivé acylé
|
CA2870313A1
(fr)
|
2012-04-11 |
2013-10-17 |
Novo Nordisk A/S |
Formulations a base d'insuline
|
WO2013164375A1
(fr)
|
2012-05-01 |
2013-11-07 |
Novo Nordisk A/S |
Composition pharmaceutique
|
EP2925345B1
(fr)
|
2012-12-03 |
2018-09-05 |
Merck Sharp & Dohme Corp. |
Méthode de préparation d'insuline et d'analogues d'insuline à base du peptide de la partie terminale carboxy (ctp) o-glycosylé
|
EP2991672A1
(fr)
|
2013-04-30 |
2016-03-09 |
Novo Nordisk A/S |
Schéma d'administration d'un nouveau type
|
ES2927607T3
(es)
|
2013-09-13 |
2022-11-08 |
Scripps Research Inst |
Agentes terapéuticos modificados y composiciones de los mismos
|
WO2015052088A1
(fr)
*
|
2013-10-07 |
2015-04-16 |
Novo Nordisk A/S |
Nouveau dérivé d'un analogue de l'insuline
|
EP4212180A1
(fr)
|
2013-12-18 |
2023-07-19 |
The Scripps Research Institute |
Agents thérapeutiques modifiés, conjugués lipidiques peptidiques agrafés et compositions associées
|
AR099569A1
(es)
|
2014-02-28 |
2016-08-03 |
Novo Nordisk As |
Derivados de insulina y los usos médicos de estos
|
WO2015196174A1
(fr)
|
2014-06-20 |
2015-12-23 |
Greene Howard E |
Dispositifs et procédés d'administration de perfusion
|
CN107921098A
(zh)
|
2015-06-17 |
2018-04-17 |
加州生物医学研究所 |
修饰的治疗剂及其组合物
|
JP2018531900A
(ja)
|
2015-08-25 |
2018-11-01 |
ノヴォ ノルディスク アー/エス |
新規インスリン誘導体及びその医学的使用
|
EP3495384A4
(fr)
*
|
2016-08-02 |
2020-02-26 |
Jiangsu Hengrui Medicine Co., Ltd. |
Dérivé acylé de l'insuline humaine ou son analogue
|
EP3329930A1
(fr)
|
2016-12-05 |
2018-06-06 |
Nuritas Limited |
Compositions pharmaceutiques
|
ES2932498T3
(es)
|
2016-12-05 |
2023-01-20 |
Nuritas Ltd |
Composiciones que comprenden el péptido WKDEAGKPLVK
|
MX2019006463A
(es)
|
2016-12-16 |
2019-08-14 |
Novo Nordisk As |
Composiciones farmaceuticas que contienen insulina.
|
KR102665710B1
(ko)
|
2017-08-24 |
2024-05-14 |
노보 노르디스크 에이/에스 |
Glp-1 조성물 및 그 용도
|
KR20190038456A
(ko)
*
|
2017-09-29 |
2019-04-08 |
한미약품 주식회사 |
효력이 향상된 지속성 단백질 결합체
|
WO2019125879A2
(fr)
|
2017-12-18 |
2019-06-27 |
Merck Sharp & Dohme Corp. |
Systèmes à base de conjugués pour l'administration contrôlée d'insuline
|
EP3727424A4
(fr)
|
2017-12-18 |
2021-10-27 |
Merck Sharp & Dohme Corp. |
Systèmes à base de conjugués pour l'administration contrôlée d'insuline
|
EP3750998A4
(fr)
|
2018-02-09 |
2022-02-23 |
Jiangsu Hengrui Medicine Co., Ltd. |
Gène précurseur à codon optimisé et gène de peptide signal de l'analogue de l'insuline humaine
|
EP3805257A4
(fr)
|
2018-05-24 |
2022-03-16 |
Jiangsu Hengrui Medicine Co., Ltd. |
Procédé de préparation d'un précurseur d'insuline humaine recombinée ou d'un analogue associé
|
US10335464B1
(en)
|
2018-06-26 |
2019-07-02 |
Novo Nordisk A/S |
Device for titrating basal insulin
|
KR102666154B1
(ko)
|
2018-08-08 |
2024-05-20 |
주식회사 대웅제약 |
지속형 인슐린 아날로그 및 그 복합체
|
CA3122637A1
(fr)
|
2018-12-11 |
2020-06-18 |
Sanofi |
Liant peptidique
|
KR20200080748A
(ko)
|
2018-12-27 |
2020-07-07 |
주식회사 폴루스 |
음이온 교환 크로마토그래피를 이용한 인슐린 전구체의 정제방법
|
KR20200080747A
(ko)
|
2018-12-27 |
2020-07-07 |
주식회사 폴루스 |
인슐린 전구체의 인슐린 효소 전환용 조성물 및 이를 이용하여 인슐린 전구체를 인슐린으로 전환하는 방법
|
CN111909255A
(zh)
*
|
2019-05-10 |
2020-11-10 |
宁波鲲鹏生物科技有限公司 |
胰岛素衍生物及其制备方法
|
TWI844709B
(zh)
|
2019-07-31 |
2024-06-11 |
美商美國禮來大藥廠 |
鬆弛素(relaxin)類似物及其使用方法
|
BR112022009510A2
(pt)
|
2019-12-11 |
2022-08-16 |
Novo Nordisk As |
Análogo de insulina, composição farmacêutica, e, método de tratamento, prevenção ou alívio de uma doença ou distúrbio ou condição
|
JP2023510218A
(ja)
|
2019-12-30 |
2023-03-13 |
ガン アンド リー ファーマスゥーティカルズ カンパニー リミテッド |
長時間作用型glp-1化合物
|
CN118420744A
(zh)
|
2019-12-30 |
2024-08-02 |
甘李药业股份有限公司 |
胰岛素衍生物
|
US20230082544A1
(en)
|
2020-02-18 |
2023-03-16 |
Novo Nordisk A/S |
Pharmaceutical formulations
|
AU2021247169A1
(en)
|
2020-03-31 |
2022-10-20 |
Protomer Technologies Inc. |
Conjugates for selective responsiveness to vicinal diols
|
CA3198757A1
(fr)
|
2020-11-19 |
2022-05-27 |
Protomer Technologies Inc. |
Composes aromatiques contenant du bore et analogues d'insuline
|
EP4299057A1
(fr)
|
2022-06-30 |
2024-01-03 |
Adocia |
Compositions solides comportant un peptide ou une protéine et un acide aminé acylé
|
EP4180060A1
(fr)
|
2021-11-15 |
2023-05-17 |
Adocia |
Compositions solides comportant un peptide ou une protéine et un acide aminé acylé
|
WO2023084118A1
(fr)
|
2021-11-15 |
2023-05-19 |
Adocia |
Compositions solides comprenant un peptide ou une protéine et un acide aminé acylé
|
CN118574842A
(zh)
|
2022-01-28 |
2024-08-30 |
甘李药业股份有限公司 |
酰化胰岛素
|
EP4299071A1
(fr)
|
2022-07-01 |
2024-01-03 |
Adocia |
Compositions comprenant un peptide ou une protéine et un acide aminé acylé
|
WO2024051787A1
(fr)
*
|
2022-09-09 |
2024-03-14 |
北京惠之衡生物科技有限公司 |
Dérivé d'insuline acylé à action prolongée et son utilisation
|